Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent
In Brief: GAO Says Congress Should Re-Examine Delaney Clause, Consider Making It More Flexible
CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments
Aging Institute Encourages Cancer Investigators To Include Elderly
BRMP Investigators Find New Lung Tumor Antigen, Seek Developers
Summit Conference Reviews Leads In Leukemia, Lymphoma
Cell Behavior Changes Noted At Baltimore Symposium
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition
